Treatment of myasthenia. II.
D001285:Atropine / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D009135:Muscular Diseases / Q000188:drug therapy; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D006146:Guanidines; D009388:Neostigmine; D001285:Atropine; D011729:Pyridostigmine Bromide